Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Access


Guru

Status: Offline
Posts: 1724
Date:
RE: Access
Permalink  
 


No mystery here.  The reason Harvoni is so difficult to access is cost, and it is a worldwide problem, not merely a US problem.  Consider that the cost of a 24 week course of tx is the equivalent of the average US household income for ~ 4 years!!   One course costs as much as the average house.  That is the source of the problem and it is outrageous.  

Rationing was unheard of when the tx was Interferon/Riba or even the first gen protease inhibitors.  But I'm sure Pharma loves it when insurance companies take the heat--while Gilead comes to the rescue of the select few who can get approval by picking up their co-pay--all for a drug that costs a couple of hundred to manufacture.  Profits are one thing but holding patients hostage is obscene.  

Payers --all over the world--are stalling and rationing because the costs are too high.  The free market system is supposed to correct this but the reality is that healthcare and pharma costs are out of control and entirely unsustainable in the long term.  

 



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.

Tig


Admin

Status: Offline
Posts: 9284
Date:
Permalink  
 

Have you considered the possibility of the delay being the result of the upcoming mid term US elections and the new ACA changes set to occur in January? I was just notified that my insurance plan is going to be cancelled before year's end. That makes 4 times this calendar year alone, that my insurance was cancelled because of changes brought on by the ACA/OBAMACARE legislation. Who knows what the reason is for all of these delays, but I guarantee you one thing, it has something to do with price...

Tig



__________________

Tig

68yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Senior Member

Status: Offline
Posts: 123
Date:
Permalink  
 

It is absurd that the insurance companies are still deciding their criteria for approval for Harvoni.  Sovaldi was approved almost a year ago &  Gilead filed for approval for Harvoni 8 months ago & the approval decision was almost instantly scheduled for 10/10. It shouldn't have been any surprise.  I actually think this is a planned stalling tactic.



__________________

Miss B
56 years old. Genotype 1B, previous treatment with interferon 1994. Started Harvoni 12/8/14. After 2 weeks, VL dropped from over 4 million to 496. At 4 weeks, undetected, but at 8 weeks, <15 mL (detected), at 12 weeks/EOT UND!  



Senior Member

Status: Offline
Posts: 115
Date:
Permalink  
 

It is amazing to me that my insurance is slow to provide Harvoni.  In the past, FDA approved drug for an FDA approved indication where there are not any alternatives was a very simple situation.  You could get the drug.  There is no good reason for the availability to be stalled.  However, in my case, there is a process of vetting the drug that will not change any of the facts.  It will only make me wait.  While I well understand the issues with cost of health care, the dumbing down of the process with non-physicians making critical decisions stinks.  One of the statements that I received is that the delay will not hurt me....how does the non-physician who said this know.

 

And yes, if not obvious, this does piss me off!!



__________________
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.